Thyrocare International Limited, a struck off public limited company, was established on 14 May 2012 in Navi Mumbai, Maharashtra, India. Engaging in financial holding companies within the financial services sector, it holds CIN: U74120MH2012PLC230995. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹1.50 M.
It upholds a compliant status. Its leadership includes Anand Velumani (Director), Velumani Arokiaswamy (Director), Sundararaju Arokiaswamy (Director). Past directors included Rajendra Bhaskar Halve. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 2Nd Floor, Plot No: D-123, Ttc, Midc Village Shirvane, Node Nerul, Navi Mumbai, Maharashtra, 400706.
U74120MH2012PLC230995
230995
14 May 2012
₹5.00 M
₹1.50 M
Roc Mumbai
Unlisted
Struck Off
Explore comprehensive insights into Thyrocare International Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Anand Velumani | Director | 14 May 2012 | Current |
| Velumani Arokiaswamy | Director | 14 May 2012 | Current |
| Sundararaju Arokiaswamy | Director | 14 May 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 12 May 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Thyrocare International Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 3979.79% increase in profit. The company's net worth Soared by an impressive increase of 111.61%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Thyrocare International had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Thyrocare International, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Thyrocare International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Thyrocare International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Thyrocare International Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Thyrocare International Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Mumbai. was recorded as a recent event.
The activity Anand Velumani was appointed as a Director was appointed as a Director on 14 May 2012 & has been associated with this company since 13 years 6 months . was completed.
Velumani Arokiaswamy was appointed as a Director was appointed as a Director on 14 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.
Sundararaju Arokiaswamy was appointed as a Director was appointed as a Director on 14 May 2012 & has been associated with this company since 13 years 6 months . was recorded as a recent event.
Progress on Thyrocare International Limited was registered on 14 May 2012 with Roc Mumbai & aged 13 years 6 months as per MCA records. was documented.
Recently accreditation were received for nine additional processing laboratories in Bhopal, Guwahati, Bengaluru, Chennai, Patna, Bhubaneswar, Raipur, Lucknow and Ranchi Thyrocare has achieved National.
Norwest Venture Partners sold 9.3% of Thyrocare Technologies for Rs335 crore. Reliance and Birla Sunlife bought some shares. Norwest owns 9.43% of the company. They have $6 billion. Reliance bought 11.3 lakh shares for Rs75.71 lakh and Birla Sunlife bought 10 lakh shares for Rs67 crore. The stock went down 4.39% on Monday..
The CIN of Thyrocare International Limited is U74120MH2012PLC230995.
Thyrocare International Limited is headquartered at 2Nd Floor, Plot No: D-123, Ttc, Midc Village Shirvane, Node Nerul, Navi Mumbai, Maharashtra, 400706.
Thyrocare International Limited was incorporated on 14 May 2012.
The current directors of Thyrocare International Limited are
The primary industry of Thyrocare International Limited is Financial Services.
Thyrocare International Limited is unlisted.
The authorized capital of Thyrocare International Limited is ₹5.00 M, and the paid-up capital is ₹1.50 M.
The compliance status of Thyrocare International Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX